Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2017

Open Access 01-10-2017 | Breast Oncology

Keynote Address at the American Society of Breast Surgeons 18th Annual Meeting

Current and Future Application of Intraoperative Radiotherapy (IORT) in the Curative and Palliative Treatment of Breast Cancer

Author: Frederik Wenz

Published in: Annals of Surgical Oncology | Issue 10/2017

Login to get access

Abstract

Intraoperative radiotherapy (IORT) is increasingly used worldwide. Breast cancer is the most rapidly growing indication for IORT, approaching 70–80% of cases in most centers. This report reviews the theoretical background and clinical use of IORT for primary and metastasized breast cancer. There are established applications such as tumor bed boost during breast-conserving surgery followed by whole breast radiotherapy or IORT as a form of accelerated partial-breast irradiation (APBI) for selected patients. Novel applications such as IORT for vertebral or brain metastases are presented as well as technological developments, widening the spectrum of potential clinical applications for IORT.
Literature
1.
Krengli M, Calvo FA, Sedlmayer F, Sole CV, Fastner G, Alessandro M, et al. Clinical and technical characteristics of intraoperative radiotherapy: analysis of the ISIORT-Europe database. Strahlenther Onkol. 2013;189:729–37.CrossRefPubMed
2.
Krengli M, Sedlmayer F, Calvo FA, Sperk E, Pisani C, Sole CV, et al. ISIORT pooled analysis 2013 update: clinical and technical characteristics of intraoperative radiotherapy. Transl Cancer Res. 2014;3:48–58.
3.
Herskind C, Wenz F. Radiobiological aspects of intraoperative tumor-bed irradiation with low energy x-rays (LEX-IORT). Transl Cancer Res. 2014;3:3–17.
4.
Veldwijk MR, Zhang B, Wenz F, Herskind C. The biological effect of large single doses: a possible role for non-targeted effects in cell inactivation. PLoS One. 2014;9:e84991.CrossRefPubMedPubMedCentral
5.
Wenz F, Sedlmayer F, Herskind C, Welzel G, Sperk E, Neumaier C, et al. Accelerated partial breast irradiation in clinical practice. Breast Care Basel. 2015;10:247–52.CrossRefPubMedPubMedCentral
6.
Herskind C, Ma L, Liu Q, Zhang B, Schneider F, Veldwijk MR, Wenz F. Biology of high single doses of IORT: RBE, 5 R’s, and other biological aspects. Radiat Oncol. 2017;12:24.CrossRefPubMedPubMedCentral
7.
Wenz F, Blank E, Welzel G, Hofmann F, Astor D, Neumaier C, et al. Intraoperative radiotherapy during breast-conserving surgery using a miniature x-ray generator (Intrabeam) theoretical and experimental background and clinical experience. Women’s Health. 2012;8:39–47.CrossRefPubMed
8.
Fastner G, Sedlmayer F, Merz F, Deutschmann H, Reitsamer R, Menzel C, et al. IORT with electrons as boost strategy during breast-conserving therapy in limited-stage breast cancer: long-term results of an ISIORT pooled analysis. Radiother Oncol. 2013;108:279–86.CrossRefPubMed
9.
Wenz F, Welzel G, Blank E, Hermann B, Steil V, Suetterlin M, et al. Intraoperative radiotherapy (IORT) as a boost during breast-conserving surgery (BCS) using low kV X-rays: the first five years of experience with a novel approach. Int J Radiat Oncol Biol Phys. 2010;77:1309–14.CrossRefPubMed
10.
Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:121–8.CrossRefPubMed
11.
Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al. Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO): 5-year results of accelerated partial-breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;387: 229–38.CrossRefPubMed
12.
Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, et al. TARGeted Intraoperative radioTherapy Alone versus whole-breast radiotherapy for breast cancer (TARGIT-A trial): results of an international prospective randomised phase III trial. Lancet. 2010;376:91–102.CrossRefPubMed
13.
Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, et al. On behalf of the TARGIT trialists’ group. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383:603–13.CrossRefPubMed
14.
Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013;14:1269–77.CrossRefPubMed
15.
Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, et al. Accelerated partial-breast irradiation using intensity-modulated radiotherapy versus whole-breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451–63.CrossRefPubMed
16.
Vaidya JS, Bulsara M, Wenz F, Coombs N, Singer J, Ebbs S, et al. Reduced mortality with partial-breast irradiation for early breast cancer: a meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys. 2016;96:259–65.CrossRefPubMed
17.
Abo-Madyan Y, Welzel G, Sperk E, Neumaier C, Keller A, Clausen S, et al. Intraoperative (IORT) versus whole-breast radiation therapy (WBRT) for early breast cancer: single-center results from the randomized phase 3 TARGIT-A trial. Int J Radiat Oncol Biol Phys. 2016;96(Suppl):E16–17.CrossRef
18.
Wenz F. First outcome analysis of the TARGIT E(lderly) trial: prospective phase 2 study of intraoperative radiation therapy (IORT) in elderly patients with small breast cancer. Int J Radiat Oncol Biol Phys. 2016;96(Suppl):E8–9.CrossRef
19.
Sperk E, Astor D, Keller A, Welzel G, Gerhardt A, Tuschy B, et al. A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer. Radiat Oncol. 2014; 9:154.CrossRefPubMedPubMedCentral
20.
Wenz F, Schneider F, Neumaier C, Kraus-Tiefenbacher U, Reis T, Schmidt R, et al. Kypho-IORT: a novel approach of intraoperative radiotherapy during kyphoplasty for vertebral metastases. Radiat Oncol. 2010;5:11.CrossRefPubMedPubMedCentral
21.
Schneider F, Greineck F, Clausen S, Mai S, Obertacke U, Reis T, et al. Development of a novel method for intraoperative radiotherapy during kyphoplasty for spinal metastases (Kypho-IORT). Int J Radiat Oncol Biol Phys. 2011;81:1114–9.CrossRefPubMed
22.
Reis T, Schneider F, Welzel G, Schmidt R, Bludau F, Obertacke U, et al. Intraoperative radiotherapy during kyphoplasty for vertebral metastases (Kypho-IORT): first clinical results. Tumori. 2012;98:434–40.PubMed
23.
Reis T, Sperk E, Schneider F, Bludau F, Obertacke U, Wenz F. Intraoperative radiotherapy during kyphoplasty (Kypho-IORT): a novel treatment approach for patients with symptomatic spinal metastases. Transl Cancer Res. 2015;4:155–60.
24.
25.
26.
Kraus-Tiefenbacher U, Bauer L, Schöber C, Schaefer J, Steil V, Wenz F. Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy. BMC Cancer. 2007;7:178.CrossRefPubMedPubMedCentral
27.
Schneider F, Clausen S, Thölking J, Wenz F, Abo-Madyan Y. A novel approach for superficial intraoperative radiotherapy (IORT) using a 50 kV x-ray source: a technical and case report. J Appl Clin Med Phys. 2014;15:4502.CrossRefPubMed
28.
Kraus-Tiefenbacher U, Blank E, Wenz F. Intraoperative radiotherapy (IORT) during a second breast-conserving procedure for relapsed breast cancer after previous external beam radiotherapy (EBRT). Int J Radiat Oncol Biol Phys. 2011;80:1279–80.CrossRefPubMed
29.
Guix B, Lejarcegui JA, Tello JI, et al. Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study. Int J Radiat Oncol Biol Phys. 2010;78:804–10.CrossRefPubMed
30.
Hannoun-Levi JM, Houvenaeghel G, Ellis S, et al. Partial-breast irradiation as second treatment for local breast cancer recurrence. Int J Radiat Oncol Biol Phys. 2004;60:1385–92.CrossRefPubMed
Metadata
Title
Keynote Address at the American Society of Breast Surgeons 18th Annual Meeting
Current and Future Application of Intraoperative Radiotherapy (IORT) in the Curative and Palliative Treatment of Breast Cancer
Author
Frederik Wenz
Publication date
01-10-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 10/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-5942-z

Other articles of this Issue 10/2017

Annals of Surgical Oncology 10/2017 Go to the issue

Breast Oncology

Breast Cancer Disparities: Socioeconomic Factors versus Biology

Breast Oncology

A Single Institution Retrospective Comparison Study of Locoregional Recurrence After Accelerated Partial Breast Irradiation Using External Beam Fractionation Compared with Whole Breast Irradiation with 8 Years of Follow-Up

Breast Oncology

Socioeconomic Factors Associated with Post-Mastectomy Immediate Reconstruction in a Contemporary Cohort of Breast Cancer Survivors

Breast Oncology

Nipple-Sparing Mastectomy: Pitfalls and Challenges

Breast Oncology

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options

Breast Oncology

Positive Ultrasound-guided Lymph Node Needle Biopsy in Breast Cancer may not Mandate Axillary Lymph Node Dissection